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Microbiota influence diverse aspects of intestinal physiology and disease in part by controlling tissue-specific transcription
of host genes. However, host genomic mechanisms mediating microbial control of intestinal gene expression are poorly un-
derstood. Hepatocyte nuclear factor 4 (HNF4) is the most ancient family of nuclear receptor transcription factors with im-
portant roles in human metabolic and inflammatory bowel diseases, but a role in host response to microbes is unknown.
Using an unbiased screening strategy, we found that zebrafish Hnf4a specifically binds and activates a microbiota-sup-
pressed intestinal epithelial transcriptional enhancer. Genetic analysis revealed that zebrafish hnf4a activates nearly half
of the genes that are suppressed by microbiota, suggesting microbiota negatively regulate Hnf4a. In support, analysis of
genomic architecture in mouse intestinal epithelial cells disclosed that microbiota colonization leads to activation or inacti-
vation of hundreds of enhancers along with drastic genome-wide reduction of HNF4A and HNF4G occupancy. Interspecies
meta-analysis suggested interactions between HNF4A and microbiota promote gene expression patterns associated with
human inflammatory bowel diseases. These results indicate a critical and conserved role for HNF4A in maintaining intes-
tinal homeostasis in response to microbiota.
[Supplemental material is available for this article.]
All animals face the fundamental challenge of building and main-
taining diverse tissues while remaining sensitive and responsive to
their environment. This ismost salient in the intestinal epithelium
which performs important roles in nutrient absorption and barrier
function while being constantly exposed to complex microbial
communities (microbiota) and nutrients within the intestinal lu-
men. The presence and composition of microbiota in the intesti-
nal lumen influence diverse aspects of intestinal development
and physiology including dietary nutrient metabolism and ab-
sorption, intestinal epithelial renewal, and edification of the
host immune system. Abnormal host-microbiota interactions are
strongly implicated in the pathogenesis of inflammatory bowel
diseases (IBD), including Crohn’s disease (CD) and ulcerative coli-
tis (UC) (Sartor and Wu 2016). Studies in mouse and zebrafish
models of IBD have established that impaired intestinal epithelial
cell (IEC) responses to microbiota are a key aspect of disease pro-
gression (Bates et al. 2007; Kamada et al. 2013; Marjoram et al.
2015). Improved understanding of the molecular mechanisms by
which microbiota evoke host responses in the intestinal epitheli-
um can be expected to lead to new strategies for preventing or
treating IBD and other microbiota-associated diseases.
The ability of IECs to maintain their physiologic functions
and respond appropriately to microbial stimuli is facilitated
through regulation of gene transcription. Genome-wide compari-
son of transcript levels in intestinal tissue or isolated IECs from
mice reared in the absence of microbes (germ-free or GF) to those
colonized with a microbiota (conventionalized or CV) have re-
vealed hundreds of genes that have significantly increased or de-
creased mRNA levels following microbiota colonization (Camp
et al. 2014). Interestingly, many mouse genes that are transcrip-
tionally regulated by microbiota have zebrafish homologs that
are similarly responsive, suggesting the existence of evolutionarily
conserved regulatorymechanisms (Rawls et al. 2004). For example,
the protein hormone Angiopoetin-like 4 (ANGPTL4, also called
FIAF) is encoded by a single ortholog in the mouse and zebrafish
genomes, andmicrobiota colonization results in significant reduc-
tions in transcript levels in the intestinal epithelium of both host
species (Bäckhed et al. 2004; Camp et al. 2012). Whereas these
impacts ofmicrobiota on host IEC transcriptomes and their down-
stream consequences have been extensively documented, the
upstream transcriptional regulatory mechanisms remain poorly
understood.
Specification and tuning of gene transcription proceeds, in
part, through interactions between transcription factors (TFs) and
their sequence-specific binding to cis-regulatory DNA. Cis-regula-
tory regions (CRRs) harbor binding sites for multiple activating or
repressing TFs and are generally associated with nucleosome
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depletion and specific post-translational modifications of histone
proteins within adjacent nucleosomes when acting as poised
(H3K4me1) or active (H3K27ac) enhancers (Creyghton et al.
2010). Antibiotic administration can impact transcript levels and
histonemodifications in IECs (Thaiss et al. 2016); however, it’s un-
clear if these changes are indirect effects caused by alterations to
microbiota composition, direct effects of the antibiotic on host
cells, or the effects of remaining antibiotic-resistant microbiota
(Morgun et al. 2015). Previous studies have shown that histone
deacetylase 3 is required in IECs tomaintain intestinal homeostasis
in thepresenceofmicrobiota (Alenghat et al. 2013) and thatoverall
histone acetylation and methylation in the intestine is altered by
microbiotacolonization (Krautkrameret al. 2016).However, thedi-
rect and specific effects of the microbiota on host CRRs and subse-
quent transcriptional responses in IECs remain unknown.
Ourprevious studies predictedkey roles foroneormorenucle-
ar receptor (NR) TFs in microbial down-regulation of IEC gene
expression (Camp et al. 2014), but the specific TF(s) were not
identified. Nuclear receptors are ideal candidate TFs for integrating
microbe-derived signals since, for many, their transcriptional
activity can be positively or negatively regulated by the binding
of metabolic or hormonal ligands (Evans and Mangelsdorf 2014).
However, the roles of nuclear receptors in host responses remain
poorly understood, and no previous study has defined the impact
of microbiota on nuclear receptor DNA binding. Nuclear receptors
are a metazoan innovation. The earliest animals encoded a single
nuclear receptor orthologous to Hepatocyte nuclear factor 4
(HNF4; nuclear receptor subfamily NR2A) (Bridgham et al. 2010).
Despite subsequent duplication and diversification, distinct
HNF4 TFs remain encoded in extant animals including mam-
mals (HNF4A, HNF4G) and fishes (Hnf4a, Hnf4b, Hnf4g)
(Supplemental Fig. S1G). HNF4A serves particularly important
roles in IECs, where it bindsCRRs and activates expression of genes
involved in IEC maturation and function (Stegmann et al. 2006).
The IEC-specific knockout of mouse Hnf4a results in spontaneous
intestinal inflammation similar to human IBD (Darsigny et al.
2009). In accord, genetic variants at human HNF4A are associated
with risk for both UC and CD as well as colon cancer (Barrett et al.
2009; Jostins et al. 2012; Marcil et al. 2012; Chellappa et al. 2016).
HNF4A is predicted to bind a majority of IBD-linked CRRs and to
regulate IBD-linked genes (Haberman et al. 2014; Meddens et al.
2016). Similarly, genetic variants near human HNF4G have been
associated with obesity and CD (Franke et al. 2007; Berndt et al.
2013). Importantly, these diverse roles for HNF4 TFs in host phys-
iology have only been studied in animals colonized with micro-
biota. Therefore, the role of HNF4 in host-microbiota interactions
and the implications for human IBD remain unknown.
Results
Hnf4a is essential for transcriptional activity from a microbiota-
suppressed cis-regulatory DNA region
To identify transcriptional regulatory mechanisms underlying mi-
crobial control of host gene expression,we took advantage of a pre-
viously identifiedmicrobiota-responsive CRR termed in3.4 located
within the third intron of zebrafish angptl4 (Fig. 1A). A GFP report-
er construct under control of in3.4 termed in3.4:cfos:gfp drives IEC-
specific expression of GFP in zebrafish IECs and is suppressed by
microbiota colonization, recapitulating the microbial suppression
of zebrafish angptl4 (Camp et al. 2012). However, the factor(s) that
mediate microbial suppression of in3.4 were unknown. Using a
yeast one-hybrid (Y1H) assay, we tested the capacity of 150 TFs
expressed in the zebrafish digestive system to bind in3.4
(Supplemental Fig. S1A,B; Supplemental Table S1) and detected
an interaction only with Hnf4a, Hnf4b, and Hnf4g (Fig. 1B).
When either of two predicted HNF4A motifs in in3.4 are mutated,
Hnf4-in3.4 interactions in the Y1H assay and intestinal GFP
expression in in3.4:cfos:gfp zebrafish were strongly reduced
(Supplemental Fig. S1C–F). Interestingly, while Gata4, Gata5,
and Gata6 have predictedmotifs in in3.4 (Camp et al. 2012), these
TFs did not interact in the Y1H assay. This suggests that zebrafish
Hnf4 TFs are capable of binding in3.4 directly and predicted
HNF4Abindingmotifs are necessary for directing in3.4-based tran-
scription in vitro and in the intestine.
We hypothesized that the hnf4 transcription factor family is
required to mediate microbial suppression of in3.4 activity.
Although the Y1H assay demonstrated that all three zebrafish
Hnf4 members are capable of binding in3.4, we concentrated
our efforts on understanding the function of Hnf4a because it is
the most highly conserved Hnf4 family member (Supplemental
Fig. S1G; Supplemental Table S10) and has well-documented roles
in intestinal physiology (San Roman et al. 2015). To that end, we
generated hnf4a mutant zebrafish using the CRISPR/Cas9 system
(Fig. 1C; Supplemental Fig. S2A–C,E). Whole-animalHnf4a knock-
outmice die during early embryogenesis due to failure to develop a
visceral endoderm (Duncan et al. 1997), but zebrafish and other
fishes do not develop that extra-embryonic tissue. We found
that zebrafish homozygous for a nonsense allele of hnf4a are viable
and survive to sexual maturity (Supplemental Fig. S2D), providing
new opportunities to study the roles of HNF4A in host-microbiota
interactions.
To determine if Hnf4a is essential for in3.4 activity, we
crossed mutant hnf4a alleles to the in3.4:cfos:gfp transgenic report-
er line. GFP expression was significantly reduced in the absence of
Hnf4a, suggesting that Hnf4a activates in3.4 (Fig. 1D,E,G,H). This
loss of GFP expression in hnf4a−/−mutants was not associatedwith
overt defects in brush border development or epithelial polarity in
larval stages (Fig. 1F) nor in the establishment of intestinal folds
during adult stages (Fig. 1G). However, intestinal lumen ofmutant
larvae was reduced in size at 6 d post-fertilization (dpf) compared
to WT siblings (Fig. 1F; Supplemental Fig. S2F). Together, these
data indicate Hnf4a is essential for robust activity of a micro-
biota-suppressed CRR. Unlike in3.4:cfos:gfp, angptl4 is expressed
in multiple tissues and cell types (Camp et al. 2012). To determine
if intestinal angptl4 expression is dependent on Hnf4a function,
we isolated RNA from IECs from hnf4a+/+ and hnf4−/− adult
in3.4:cfos:gfp zebrafish and performed qRT-PCR. Adult IECs
(AIECs) from hnf4a−/− have significant reductions in mRNA for
gfp and hnf4a compared to hnf4a+/+ controls. However, angptl4
expression remained unchanged in hnf4−/− AIECs compared to
WT, suggesting angptl4 transcript levels in the adult intestine are
regulated by additional mechanisms and not solely from
in3.4 or Hnf4a (Fig. 1H). Transcript levels for hnf4g and hnf4b in
hnf4a−/−AIEC were also unchanged. Together, these results estab-
lish that Hnf4a is required for in3.4 activity in IECs and raises
the possibility that Hnf4a may have broader roles in mediating
host transcriptional and physiological responses to microbiota.
Hnf4a activates transcription of genes that are suppressed
upon microbiota colonization
To better define the roles of Hnf4a inmicrobiota response and oth-
er aspects of digestive physiology, we used RNA-seq to compare
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mRNA levels from digestive tracts isolated from hnf4a+/+ and
hnf4a−/− zebrafish larvae in the presence (CV) or absence of a
microbiota (GF) (Fig. 2A). Consistent with our previous studies
(Rawls et al. 2004; Kanther et al. 2011), comparison of wild-type
zebrafish reared under CV vs. GF conditions revealed differential
expression of 598 genes that were enriched for processes such as
DNA replication, oxidation reduction, and response to bacterium
(Fig. 2B,D; Supplemental Fig. S3; Supplemental Tables S2, S4).
Strikingly, disruption of the hnf4a gene caused gross dysregulation
of the transcriptional response tomicrobiotacolonization,with the
total number of microbiota responsive
genes (CV vs. GF) increasing to 2217.
Furthermore, comparison of the hnf4a
mutant (Mut) vs. wild-type (WT) geno-
types revealed differential expression of
many genes in the CV condition (2741
genes) and GF condition (1441 genes)
that inform a general role for Hnf4a in
regulating genes in the intestinal tract
(Fig. 2D,E). Principal components analy-
sis (Supplemental Fig. S3A) andhierarchi-
cal clustering (Fig. 2B) of FPKM values
indicated that the hnf4a genotype had a
complexcontribution to regulatinggenes
involved in both responses to the micro-
biota and digestive physiology.
Because we found that Hnf4a acti-
vates the microbiota-suppressed intesti-
nal CRR, in3.4, we hypothesized that
this may represent a general regulatory
paradigm for other microbiota-influ-
encedCRRsandgenes across thegenome.
When we compared the 598 genes that
were microbiota responsive in wild-type
digestive tracts with the 2741 genes that
Hnf4a regulates in CV digestive tracts,
we found these lists shared 295 genes
that included fads2 and saa, both of
which have human orthologs that are ei-
ther implicated (FADS1/2) or markers
(SAA) of IBD (Fig. 2C–F; Plevy et al.
2013; Costea et al. 2014). While loss of
Hnf4a could be pleiotropic, strikingly,
the overlap between these subsets reveals
that a disproportionate 88 of the 98
(∼90%) microbiota-suppressed genes are
activated by Hnf4a (Fig. 2F; Supplemen-
tal Table S2). These 88 genes represent al-
most half of all 185 genes suppressed by
the microbiota. These data suggest, like
its role at in3.4, Hnf4a plays a critical
role in directly activating a large percent-
age of genes that are suppressed bymicro-
bial colonization. This set of Hnf4a-
activated microbiota-suppressed genes is
enriched for ontologies and pathways
involved in lipid and carbohydrate me-
tabolism, suggesting microbiota might
regulate these processes through sup-
pression ofHnf4a (Fig. 2G). Interestingly,
the top two diseases associated with this
gene set were obesity-related traits and
IBD (Fig. 2G; Supplemental Table S11). Based on these results,
we hypothesized that Hnf4a DNA binding is lost upon microbial
colonization within CRRs associated with microbiota-suppressed
genes.
HNF4A binding sites are enriched in promoters near genes
associated with microbiota-regulated H3K27ac marks
Previous attempts to identify microbial responsive enhancers ge-
nome-wide were complicated by the lack of significant changes
Figure 1. Zebrafish hnf4a is required for robust in3.4:cfos:gfp activity. (A) Schematic of the microbiota-
suppressed zebrafish enhancer, in3.4, highlighting the regions required for intestinal activity (purple)
which both contain putative HNF4 binding sites (Site 1 and Site 2) (Camp et al. 2012). (B) Image of
four plates from the Y1H assay showing the Hnf4 family of transcription factors capable of binding
in3.4 and driving expression of the antibiotic resistance reporter gene. (C) Hnf4a+/+ and Hnf4a−/− protein
cartoons showing the DNA binding domain (DBD) and hinge domain (HD). We characterized the two
with the largest lesions, a −43 bp deletion in the hinge domain (allele designation rdu14) and a +25
bp insertion in the hinge domain (allele designation rdu15), which both result in frame-shift and early
stop codons and significantly reduced transcript. (D) Stereofluorescence GFP and bright-fieldmicroscopy
showing representative hnf4a+/+ (top 3) and hnf4a−/− (bottom 3) 6dpf in3.4:cfos:gfp zebrafish. Genotype
was blinded, and samples were arranged by intensity of GFP fluorescence. (E) GFP fluorescence (mean ±
SEM) in hnf4a+/+ (n = 8), hnf4a+/− (n = 8), and hnf4a−/− (n = 8) 6-dpf in3.4:cfos:gfp zebrafish (Two-tailed t-
test: t = 17.84, 16.51, respectively, df = 14, and [∗∗∗∗] P < 0.0001). (F) Confocal microscopy showing rep-
resentative axial cross sections in 6-dpf hnf4a+/+ (n = 4) and hnf4a−43/−43 (n = 4) larval zebrafish. 4E8
antibody (yellow) labels the intestinal brush border, DAPI (blue), and phalloidin (red), and nephros
(n). (G) Bright-field microscopy (top) and stereofluorescence GFP (bottom) for representative hnf4a+/+
(n = 3) (left) and hnf4a−/− (n = 3) (right) dissected intestinal folds from adult in3.4:cfos:gfp zebrafish.
(H) Relative mRNA levels (mean ± SEM) in hnf4a+/+ (n = 3) and hnf4a−/− (n = 3) adult zebrafish intestinal
epithelial cell as measured by qRT-PCR. Two-tailed t-test: t = 0.93, 5.22, 6.56, 10.65, 0.75, 0.94, respec-
tively, df = 4, and (∗) P < 0.05, (∗∗∗) P < 0.001. See also Supplemental Figures S1 and S2.
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in chromatin DNase accessibility between GF and CV IECs from
mouse colonand ileum(Campet al. 2014). Theseprevious findings
suggested other chromatin dynamics may be involved in regulat-
ing the IEC response tomicrobiota.We therefore sought to provide
a genomic context for understanding how the microbiota alter
HNF4A activity and chromatin modifications in IECs by perform-
ing RNA-seq, DNase-seq, and ChIP-seq for the enhancer histone
modifications H3K4me1 and H3K27ac and the HNF4 TF family
members HNF4G and HNF4A in CV and GF conditions, totaling
35 data sets. We conducted these experiments in jejunal IECs
from gnotobiotic mice because (1) ChIP-grade antibodies for
mouse HNF4A and HNF4G are available, (2) the relatively large or-
gan size in mice provided sufficient numbers of IECs for ChIP-seq
experiments, and (3) we speculated that the roles of HNF4A in
host response to microbiota may be conserved to mammals. We
first performed DNase-seq in jejunal IECs from mice reared GF or
colonized for 2 wkwith a conventionalmousemicrobiota to deter-
mine the impact of microbiota colonization on chromatin accessi-
bility (Fig. 3A). In accord with previous studies that tested for
chromatin accessibility in ileal or colonic IECs from GF or CV
mice (Camp et al. 2014), we similarly found no differential
DNase hypersensitivity sites (DHSs) in GF or CV jejunum (data
not shown, but see Supplemental Fig. S4A–D; Supplemental
Tables S6, S8). These data indicate that gross accessibility changes
in chromatin do not underlie the transcription of microbiota-re-
sponsive genes in IECs.
Figure 2. Hnf4a activates the majority of coregulated genes that are suppressed by the microbiota. (A) Schematic showing the experimental timeline for
zebrafish digestive tract GF and CV hnf4a+/+ [WT] and hnf4a−/− [Mut] RNA-seq experiment (n = 3 forWTCV andWTGF and n = 2 forMutCV andMutGF). (B)
Hierarchical relatedness tree and heat map of differentially regulated genes in mutant and gnotobiotic zebrafish digestive tracts. Gene averaged log10
FPKMs for the biological replicates are represented for each of the 4007 differentially regulated genes. (C) Representative RNA-seq signal tracks at fatty
acid-desaturase 2 (fads2) and serum amyloid a (saa) loci. (D) Summary of the total number of differentially expressed genes between indicated conditions
(GF and CV) and genotype (WT and hnf4a−/− [Mut]). (E) Four-way Venn diagram showing overlaps between all 4007 differentially regulated genes. (F) The
295 coregulated genes were plotted using the log2 (FC) calculated in the WTGF/WTCV comparison (x-axis) and WTCV/MutCV (y-axis). The 88 out of 98
genes that are activated by Hnf4a but suppressed by the microbiota are highlighted (red) and (G) their GO term, KEGG pathway, and disease associations
are listed. See also Supplemental Figure S3.
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Figure 3. Microbiota colonization results in targeted alterations in enhancer activity near microbiota-responsive genes. (A) Schematic showing the gno-
tobiotic experimental timeline for testing mRNA levels and chromatin architecture in GF and CV mice. (B) MA plots from DESeq2 analysis (FDR < 0.01) of
H3K4me1 (n = 3 per condition) (left) and H3K27ac (n = 2 per condition) (right) ChIP-seq from GF and CV mouse jejunal IECs. Colored dots signify regions
significantly enriched for a histone mark in GF (blue) or CV (orange). We found 4579 unique H3K4me1 and 1354 unique H3K27ac peaks in GF and 5155
unique H3K4me1 and 893 unique H3K27ac peaks in CV. (C) Volcano plots showing pairwise comparison of RNA expression between GF (n = 2) and CV (n
= 2) jejunal IECs. Blue and orange dots represent genes associatedwith a region enriched for H3K4me1 (left) or H3K27ac (right) signal in GF or CV. (D) Two-
sided Kolmogorov-Smirnov goodness-of-fit test shows a positive relationship on average between the presence of a region enriched for H3K4me1/
H3K27ac signal in a specific colonization state and increased transcript abundance of a neighboring gene in that same colonization state. (E) Top de
novo binding site motifs found in DHSs that are flanked by regions enriched with H3K27ac signal in GF (E) or CV (F ). Representative ChIP-seq tracks high-
lighting a microbiota-regulated gene associated with differential histone marks in GF (G) (Akr1c19, aldo-keto reductase family 1, member C19) or CV (H)
(Ubd, ubiquitin D). Heat maps showing the average GF and CV H3K4me1 (I) or H3K27ac (J) signal at the 1000 bp flanking differential sites. (K,L) GO terms
and KEGG pathways enriched in genes associated with differential H3K27ac sites shown in J. See also Supplemental Figure S4.
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To test if other metrics of chromatin utilization were dynam-
ically regulated by microbiota, we performed ChIP-seq from GF
and CV mouse jejunal IECs for histone marks H3K4me1 and
H3K27ac that are enriched at poised enhancers and active enhanc-
ers, respectively (Fig. 3B). By determining the single-nearest gene
TSS within 10 kb of the differential histone marks and overlaying
these data with our new RNA-seq data sets, we found that regions
that gain poised (H3K4me1) and activated (H3K27ac) enhancers
upon colonization are associated with genes that have increased
transcript levels upon colonization (Fig. 3C,H–K; Supplemental
Fig. S4I; Supplemental Tables S3, S6, S8). Similarly, regions that
lose poised and active enhancers upon colonization are associated
with microbiota-suppressed genes (Fig. 3C,G,I,J,L; Supplemental
Fig. S4J; Supplemental Tables S3, S6, S8). A two-sided Kolmogo-
rov-Smirnov goodness-of-fit test shows a positive relationship be-
tween differential H3K4me1/H3K27ac regions and increased
transcript abundance of nearby genes in the same colonization
state (Fig. 3D). Collectively, we identified for the first time a ge-
nome-widemap of hundreds of newly identifiedmicrobial regulat-
edCRRs, suggesting thatmicrobiota regulation of host genes in the
intestinal epithelium is mechanistically linked to histone modifi-
cation changes more than gross chromatin accessibility changes
(Camp et al. 2014).
We leveraged this novel atlas ofmicrobiota-regulated enhanc-
ers and accessible chromatin to determine which TFs are predicted
to bind to these regions. An unbiased analysis found that three
HNF4A binding site motifs were significantly (P < 1 × 10−45, P <
1 × 10−28, and P < 1 × 10−13) enriched in promoters of genes associ-
ated with microbiota-suppressed enhancers (Supplemental Fig.
S4E), and STAT1 binding site motifs were significantly (P < 1 ×
10−16) enriched in promoters of genes associated with micro-
biota-activated enhancers (Supplemental Fig. S4F). Interestingly,
DHSs associatedwith differentially active enhancers were enriched
for two different sets of TF binding sites. DHSs flanked by micro-
biota-inactivated enhancers were enriched for nuclear receptor
DR1 sites, which can be recognized by HNF4A (Fang et al. 2012),
and GATA binding sites (P = 2.3 × 10−12 and 1.1 × 10−6, respective-
ly) (Fig. 3E). DHSs associated with microbiota-activated enhancers
were similarly enriched for the nuclear receptor DR1 binding sites
but also for STAT/IRF-like and ETS binding sites (P = 6.5 × 10−15
and 1.3 × 10−17, respectively) (Fig. 3F). These data suggest that nu-
clear receptors like HNF4Amay play a central role in IEC responses
to microbial colonization.
Microbiota colonization is associated with a reduction in HNF4A
and HNF4G cistrome occupancy
To directly evaluate the impact of microbiota on HNF4A activity,
we tested the plasticity of the genome-wide distribution of HNF4
family members in response to microbial colonization. HNF4A
bound 28,901 sites and HNF4G bound 21,875 sites across the ge-
nome in GF conditions in jejunal IECs, with ∼80% of these sites
being bound by both TFs. In striking contrast, the number of sites
bound by HNF4A and HNF4G in CV conditions was ∼10-fold less
(Fig. 4A,B; Supplemental Fig. S5A–D; Supplemental Tables S5, S8).
Of the 3964 HNF4A binding sites detected in CV, there were only
267 HNF4A sites that were specific to the CV condition (Supple-
mental Fig. S6A,C; Supplemental Table S8). Yet, the genes associat-
ed with these HNF4A sites that are retained in CV are enriched for
ontologies and pathways fundamental to intestinal epithelial biol-
ogy (Supplemental Fig. S6B). Surprisingly, we found that HNF4A
sites are equally distributed between genes that are up-regulated
in both GF and CV conditions (Supplemental Fig. S6E). However,
we did find that the average CV HNF4A ChIP-seq signal strength
was significantly increased at HNF4A sites associated with micro-
biota-induced genes relative to those HNF4A sites associated
with microbiota-suppressed genes, suggesting HNF4A may play a
limited role in genes up-regulated by colonization (Supplemental
Fig. S6F). In contrast, GF HNF4A ChIP-seq signal was equivalent
atHNF4A sites associatedwithmicrobiota-suppressed and induced
genes (Supplemental Fig. S6F). Interestingly, we found that HNF4A
sites correspond with increased H3K27ac, H3K4me1, and DHS sig-
nal in GF compared to these same chromatinmarks in CV (Supple-
mental Fig. S6G). We do not believe that the reduction of HNF4A
binding is the result of chromatin quality in a particular condition
since there are genomic locations where GF and CV HNF4A sites
appeared to have equivalent signal (Fig. 4C). Furthermore, ChIP
enrichment in these IEC preparations for another zinc finger TF,
CTCF, was unaffected by microbiota colonization (Supplemental
Fig. S6D). This indicates that the observed reduction of HNF4
ChIP-seq signal in CV IECs is a result of microbiota on HNF4 bind-
ing and is not the result of alteredChIP efficiencyor sample quality
in the different conditions. To test if microbial suppression of
HNF4A occupancy is persistent, we performed ChIP-PCR from
ex-GF mice that were colonized with microbiota for 6, 15, or 45
d. We found that even after 45 d post-colonization, HNF4A occu-
pancy at binding sites was significantly reduced compared to GF
(Fig. 4F). The dramatic loss of HNF4A and HNF4G DNA binding
upon colonization is consistent with HNF4A acting as a potent ac-
tivator of microbiota-suppressed genes.
We further speculated that certain coregulatory sequence-
specific transcription factors may also contribute to regulating
transcription with HNF4 at these sites. To explore this possibility,
we searched for TF motifs associated with HNF4A ChIP sites and
found an enrichment of putative binding sites for TFs known to
be involved in small intestinal physiology (GATA and HOXC9)
as well as nutrient metabolism (PDX1) at both HNF4A-bound re-
gions associated with genes and enhancers suppressed by mi-
crobes (Fig. 4D). We similarly found GATA sites located within
an HNF4A-bound CRR near murine Angptl4 (Fig. 4E), similar to
the coincident HNF4 and GATA motifs in zebrafish in3.4 (Camp
et al. 2012). Furthermore, binding sites for TFs known to be in-
volved in cell proliferation and cell death (ETS transcription factor
family) are enriched near HNF4A bound regions that intersect
microbiota-induced enhancers (Fig. 4D). Collectively, our integra-
tive analyses of these novel ChIP-seq, DNase-seq, and RNA-seq
data sets identify a core set of putative microbiota-responsive TFs
that may interact with HNF4A to mediate microbial control of
IEC gene expression. These results suggest HNF4A plays a major
role in integrating microbial signals to regulate gene expression
and raise the possibility that this novel microbiota-HNF4A axis
might contribute to human disease.
Microbiota-mediated suppression of HNF4A may contribute
to gene expression profiles associated with human IBD
Both HNF4A and the intestinal microbiota have been separately
implicated in the pathogenesis of the human IBDs Crohn’s disease
and ulcerative colitis (Ahn et al. 2008; Sartor and Wu 2016).
However, a mechanistic link between microbiota and HNF4A in
the context of IBD pathogenesis has not been established.
Previous transcriptomic studies have identified genes differentially
expressed in ileal (iCD) and colonic CD (cCD) and UC (Arijs et al.
2009; Haberman et al. 2014) biopsies. We queried these human
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Figure 4. Microbiota colonization results in extensive loss of HNF4A and HNF4G DNA binding in IECs. (A) Heat maps showing the average GF and CV
ChIP-seq or DNase-seq signal at the 1000 bp flanking HNF4A sites found in GF. (B) Line plots showing the average GF (light-colored line) and CV (dark-
colored line) ChIP-seq and DNase-seq RPKM-normalized signal for the indicated TF, histonemark, or DHS at the 1000 bp flanking HNF4A sites found in GF
(HNF4A: n = 3 per condition; HNF4G: n = 4 per condition; H3K27ac: n = 2 per condition; H3K4me1: n = 3 per condition; DNase: n = 3 for CV, n = 2 for GF).
(C) Representative signal tracks highlighting a microbiota-induced gene (Pigr, polymeric immunoglobulin receptor) that is associated with an HNF4A peak
with similar signal in bothGF andCV jejunal IECs. (D) Heatmap showing the enrichment of TFBSmotifs within 50 bp of the DHS or HNF4A peakmaxima. (E)
Representative signal track at Angptl4 highlighting two GATA4 sites within an HNF4A-bound region. (F) Bar graph showing HNF4A ChIP-PCR results at
Angptl4, Apoa1, and Pck1 loci from jejunal IECs frommice colonized for 0 (n = 2), 6 (n = 3), 15 (n = 2), and 45 (n = 3) d. Data are relative to the GF condition
and normalized against a negative control locus (Neurog1). (∗) P < 0.5, (∗∗) P < 0.005, (∗∗∗) P < 0.0005. See also Supplemental Figures S5 and S6.
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gene lists to identify one-to-one orthologs in mice and referenced
them against our new gnotobiotic mouse jejunal HNF4AChIP-seq
data (Fig. 5A). Strikingly, the majority of human genes down-reg-
ulated in each of these IBD data sets have mouse orthologs that
are associated with an HNF4A-bound region (Fig. 5B,C;
Supplemental Table S7). Focusing on the iCD data set from the
largest of these previous studies (Haberman et al. 2014), we found
that differential iCD genes associated with HNF4A sites are en-
riched for distinct ontologies and pathways that are dysregulated
in IBD (Fig. 5H–K). In contrast to IBD, analysis of intestinal
Figure 5. Microbiota suppression of HNF4A activity is highly correlated with genes and intestinal processes suppressed in human IBD and conserved in
zebrafish. (A) Flow chart showing the experimental design and filters used to identify IBD, NEC, or IR gene orthologs associated with mouse HNF4A ChIP
sites. (B) Bar chart showing the proportion of HNF4A associations in GF and CVmouse jejunal IECs near human-to-mouse one-to-one gene orthologs differ-
entially regulated in human pediatric ileal Crohn’s disease (iCD-1), adult iCD (iCD-2), adult colonic Crohn’s disease (cCD), adult ulcerative colitis (UC),
neonatal necrotizing enterocolitis (NEC), or insulin-resistance (IR). (C ) Heat map representing the −log10 (P-value) of the enrichment of GF or CV
HNF4A-associated genes that are differentially regulated genes in the indicated IBD data sets. Log10 P-values were calculated using a hypergeometric en-
richment analysis and converting all HNF4A ChIP associated mouse genes to human orthologs (GF = 5863 genes and CV = 2119 genes). (D) Flow chart
showing the experimental design and filters used to identify correlations between gnotobioticWT or mutant zebrafish gene expression and gene orthologs
differentially expressed in human IBD or NEC. Example of Deming linear regression analysis showing the correlation of log2 (FC) betweenWTCV/WTGF (E)
or MutCV/WTCV (F ) zebrafish and pediatric iCD or NEC.m = slope of the line. (G) Heat map representing slopes of Deming linear regression lines showing
positive correlative relationships between the log2 gene expression fold changes of one-to-one orthologs from human diseases compared to log2 fold
changes in zebrafish WTCV/WTGF, MutCV/MutGF, MutCV/WTCV, and MutGF/WTGF. Because loss of hnf4a function in zebrafish appeared to resemble
more closely the iCD signature than cCD or UC, we performed pairwise comparisons of gene orthologs that are (1) differentially regulated in human
iCD and (2) have a mouse HNF4A ChIP association (iCD-1 [HNF4A]) or do not have a mouse HNF4A ChIP association (iCD-1 [no HNF4A]). Hash signs in-
dicate slope of Deming linear regression lines is significantly greater thanWTCV/WTGF comparison. (#) P < 0.05, (##) P < 0.0001. Asterisks indicate slope of
Deming linear regression line is significantly greater thanMutGF/WTGF. (∗) P < 0.05, (∗∗) P < 0.001. Solid boxes correspond to slope of lines in panelD, and
dashed boxes correspond to slope of lines in panel E. (H–K ) The top five GO terms and the top five KEGG pathways for indicated gene lists.
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transcriptomic data sets fromhuman subjects with necrotizing en-
terocolitis (NEC) (Tremblay et al. 2016) or insulin-resistance (IR)
(Veilleux et al. 2015) did not reveal strong enrichment of
HNF4A-bound regions near down-regulated genes (Fig. 5C).
Notably, in each of these CD, UC, NEC, and IR data sets, a greater
percentage of down-regulated genes were linked to HNFA-bound
regions compared to up-regulated genes (Fig. 5B). These data sug-
gest that microbiota-dependent and microbiota-independent
suppression of HNF4A activity in the intestine might play an im-
portant role in IBDpathologies. To assess ifmicrobiota suppression
of HNF4A activity regulates genes differentially expressed in IBD,
we queried the published human IBD and NEC gene expression
data sets to identify human-mouse-zebrafish one-to-one-to-one
orthologs that were differentially expressed in our RNA-seq analy-
sis of gnotobiotic zebrafish hnf4amutants (Fig. 5D).We found that
ortholog expression fold changes in human IBD/healthy compar-
isons most closely resembled the expression fold changes of
MutCV/MutGF and MutCV/WTCV (Fig. 5E–G). Neither the
WTCV/WTGF nor the MutGF/WTGF comparisons faithfully reca-
pitulate the expression profiles of IBD/healthy comparisons. These
data indicate that microbiota colonization in the absence of hnf4a
function in zebrafish is sufficient to induce a gene expression pro-
file that resembles human IBD. Strikingly, the positive correlation
and significant resemblance to the iCD-like gene signatures in the
colonized hnf4a−/− compared to colonized hnf4a+/+ zebrafish di-
gestive tracts become even stronger when we limited our analysis
to one-to-one orthologs that have an association with an
HNF4A-bound region in mouse IECs (Fig. 5G). Together, these re-
sults indicate that intestinal suppression ofHNF4A target genes is a
prevalent feature of human CD and UC and suggest a model
wherein HNF4A maintains transcriptional homeostasis in the
presence of a microbiota and protects against an evolutionarily
conserved IBD-like gene expression signature.
Discussion
Over the course of animal evolution, the intestinal epithelium has
served as the primary barrier between animal hosts and the com-
plexmicrobial communities they harbor. IECsmaintain this barri-
er and perform their physiological roles in nutrient transport and
metabolism through dynamic transcriptional programs. The regu-
latorymechanisms that orchestrate these transcriptional programs
represent potential therapeutic targets for a variety of human in-
testinal diseases, including IBD. Here, we discovered that HNF4A
activity and its transcriptional network are suppressed by micro-
biota. HNF4 is the oldest member of the nuclear receptor TF family
(Bridgham et al. 2010), and our findings in fish andmammals sug-
gest that microbial suppression of HNF4A may be a conserved fea-
ture of IEC transcriptional programs present in the common
ancestor.
We discovered HNF4A as a microbiota-suppressed transcrip-
tion factor by demonstrating that it specifically binds to a micro-
biota-suppressed cis-regulatory element, in3.4, which is located at
the zebrafish gene angptl4. This finding, combined with our zebra-
fish RNA-seqdata (Fig. 2F,G), revealed a broad role forHNF4A in ac-
tivation of microbially suppressed transcripts. Though hnf4a
mutant zebrafish have reduced in3.4 activity in the intestinal epi-
thelium based on transgenic reporter assays, the transcript levels
of the endogenous zebrafish angptl4 gene appears unaffected in
both larval digestive tracts and adult IECs. The zebrafish genome
encodes two additional HNF4 family members (hnf4b, hnf4g),
and previous studies inmammals have shownAngptl4 can be regu-
lated by other metabolically activated nuclear receptors (Staiger
et al. 2009; Korecka et al. 2013). We hypothesize that loss of
HNF4A function may lead to a metabolic imbalance leading to
atypical or compensatory activation of other trans- and cis-factors
that control expression of angptl4 and other genes in the intestine.
Our results suggest new links betweenHNF4A andmicrobiota
in the context of human IBD. IBD patients, particularly those suf-
fering from Crohn’s disease, often present with decreased serum
low-density lipoprotein levels and reduced total cholesterol levels
compared to healthy individuals (Hrabovsky et al. 2009;
Agouridis et al. 2011). These serum levels are consistent with re-
duced transcript levels for genes involved in intestinal absorption
and transport of lipid and cholesterol in ileal and colonic biopsies
from UC and CD patients (Arijs et al. 2009; Haberman et al.
2014). Transcription factors, including nuclear receptors like
HNF4A and FXR, are known to regulate bile acid production and
lipid and cholesterol absorption and have already been implicated
in IBD (Ahn et al. 2008;Nijmeijer et al. 2011). Previous studies have
shown that some IBD-associated H3K27ac-activated regions that
also overlap with IBD-associated SNPs contain HNF4A binding
sites (Mokry et al. 2014). This is consistent with our findings and
supports a role for HNF4A in regulating gene expression and in-
flammation in the context of IBD. However, our work is the first
to demonstrate a role for microbiota in suppressing HNF4A and
to implicate microbiota-HNF4A interactions in driving an IBD-
like gene expression signature (Fig. 5). In addition to IBD, human
HNF4A variants are associated with metabolic syndrome
(Weissglas-Volkov et al. 2006) and type 2 diabetes (Ma et al.
2016). Interestingly, microbiota have also been implicated in
both of these diseases (Qin et al. 2012; Vrieze et al. 2012), raising
the possibility thatmicrobiota suppression of HNF4A trans activity
couldplaya role in thesediseases aswell. Indeed,we find that genes
down-regulated in intestinal tissue from IR-obese patients have in-
creased HNF4A binding associations compared to up-regulated
genes (Veilleux et al. 2015), similar to the enrichment ofHNF4Aas-
sociations atdown-regulatedgenes in IBD(Fig. 5B,C). Interestingly,
up-regulatedgenes in these IR-obesepatientswere enriched forpro-
inflammatory markers. This underscores the relationship between
metabolic impairments and inflammation in the intestine and
prompts further investigation of how HNF4A might contribute to
this relationship. HNF4A has been shown to play key roles in
anti-oxidative and anti-inflammatory defense mechanisms
(Marcil et al. 2010), so aberrant microbial suppression could pro-
mote an inflammatory state.HNF4A target genes are down-regulat-
ed in human IBD (Arijs et al. 2009; Haberman et al. 2014) and
mouse experimental colitis (Chahar et al. 2014), and the HNF4A
targetAPOA1has been shown to be protective against intestinal in-
flammation in mice (Gkouskou et al. 2016). We speculate that the
genes governed by this novel microbiota–HNF4A axis may include
additional anti- and pro-inflammatory factors that could provide
new targets for IBD therapy.
Our results reveal similar effects of microbiota colonization
and experimental colitis on HNF4A cistrome occupancy in the in-
testine, but the underlyingmolecular mechanisms are unresolved.
DSS-induced colitis results in reducedHNF4A protein levels and al-
tered cellular localization (Chahar et al. 2014); however, our results
indicate the microbiota neither reduce HNF4A protein levels nor
impact its nuclear localization in jejunal IECs 2 wk after coloniza-
tion (Supplemental Fig. S6H,I). Colonization of GF mice with
microbiota initiates a transcriptional adaptation in the intestine
that progresses for several weeks before reaching homeostasis (El
Aidy et al. 2012). However, our data indicate HNF4A suppression
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is achieved within 15 d and persists through at least 45 d after col-
onization. These data collectively suggest thatmicrobiota suppress
HNF4A activity in the jejunum throughmechanisms distinct from
those utilized in DSS-induced colitis.
HNF4A has been characterized as a master metabolic regula-
tor for its conserved roles in gluconeogenesis, glucose homeostasis,
and fatty acidmetabolism (Palanker et al. 2009; Frochot et al. 2012;
Barry and Thummel 2016). Despite its clear importance in meta-
bolic health, relatively little insight into its regulation in a biolog-
ical context has been reported. In vitro and cell culture studies
have identified possible suppressors and activators of HNF4A,
including acetylation by CREB-binding protein (CREBBP, also
known as CBP), which has been shown to induce HNF4A activity
(Soutoglou et al. 2000; Hong et al. 2003). The nuclear receptor
cofactor and master regulator of mitochondrial biogenesis
PPARGC1A binds HNF4A and promotes activation of HNF4A tar-
get genes (Rha et al. 2009). Colonization of GF animals with
microbiota leads to increased energy harvest (Rabot et al. 2010;
Semova et al. 2012) and changes inmetabolic homeostasis includ-
ing decreased AMPK complex activity in skeletal muscle and liver
(Backhed et al. 2007). Previous studies have also shown that the ac-
tivated AMPK complex phosphorylates and activates PPARGC1A
(Jager et al. 2007); therefore, microbiotamight suppress HNF4A ac-
tivity indirectly through induced alterations in metabolic homeo-
stasis. Other studies have shown that HNF4A activity is controlled
through use of alternative promoters which generate different iso-
forms (Huang et al. 2009). However, we did not detect differential
Hnf4a exon usage by DEXseq (Li et al. 2015) in our RNA-seq data
from GF and CV IECs (data not shown). Another facet of HNF4A
biology that remains unresolved is the identity of its endogenous
ligand(s). Although historically considered an orphan nuclear re-
ceptor, several fatty acids (FA), including linoleic acid, have been
identified as ligands for HNF4A (Hertz et al. 1998; Palanker et al.
2009; Yuan et al. 2009). Fatty acids are an attractive class of puta-
tive regulators of HNF4A, since the microbiota are known to regu-
late FA absorption in zebrafish IECs (Semova et al. 2012). Further,
specific bacterial taxa are known to modify the structure of poly-
unsaturated FAs (PUFAs), and these native and modified PUFAs
have distinct impacts on animal health (O’Shea et al. 2012) and
may serve as therapeutics for IBD (Mbodji et al. 2013).
In our attempt to understand how the microbiota regulate
HNF4A activity and host gene transcription, we were motivated
to investigate if microbiota impact histonemodification and chro-
matin accessibility in the mouse jejunum. Our findings support
the model that microbiota alter IEC gene expression by affecting
TF binding and histone modification at tissue-defined open chro-
matin sites (Camp et al. 2014). We provide the genomic addresses
of hundreds ofmicrobiota-regulated enhancers as well as the genes
associated with these enhancers and HNF4A binding sites. Similar
to other findings in intra-epithelial lymphocytes (Semenkovich
et al. 2016), our work demonstrates a clear microbial contribution
to the modification of the histone landscape in IECs and provides
another important layer of regulation that orchestrates microbiota
regulation of host genes involved in intestinal physiology and hu-
man disease. We were also able to establish a link between micro-
biota-regulated genes and enhancers and NR binding sites. These
NR binding sites are coincident with a core set of TFs that are
enriched near microbiota-suppressed enhancers/genes (GATA) or
induced enhancers/genes (ETS-factors and IRF) (Supplemental
Fig. S7). GATA4 was previously shown to be a positive regulator
of genes suppressed by microbiota in the mouse jejunum
(Shulzhenko et al. 2011), supporting potential coregulatory inter-
actions with HNF4A. Coregulation by other TFs represents one
possiblemode ofHNF4A regulation bywhich themicrobiota could
suppress HNF4A activitywithout impacting the gene transcription
of all HNF4A-associated genes.
Methods
Yeast one-hybrid ORFeome screen
The yeast one-hybrid ORFeome screen was performed using the
Clontech Matchmaker Gold Yeast One-hybrid Library Screening
System (cat. #630491) protocol with the following exceptions:
The Y1HGold yeast strain was transformed using standard
yeast transformation procedures with BstBI-digested pBait-AbAi
containing either the WT or a SDM in3.4 or the TP53 binding
site sequence, and positive transformants were selected on
SD/−URA media. In addition, a ORFeome library consisting of
148 zebrafish transcription factors cloned from adult zebrafish liv-
er (Supplemental Table S1) plus hnf4a and hnf4g cDNAs in
pDEST22 prey vectors containing an N-terminal GAL4-activation
domain were utilized (Boyle et al. 2017). For additional informa-
tion, see Supplemental Methods.
Mouse IEC isolation for DNase-, ChIP-, and RNA-seq
The small intestinewas removed from themouse, and the jejunum
was excised from the duodenum and ileum. Duodenum was de-
fined as the anterior 5 cm of the midgut, and ileum was defined
as posterior 6 cm of midgut as described (Camp et al. 2014).
Adipose and vasculature were removed from the tissue. The jeju-
num was opened longitudinally along the length of the tissue, ex-
posing the lumen and epithelial cell layer. Luminal debris was
washed away from the epitheliawith ice-cold sterile PBS. The tissue
was temporarily stored in 10mL of ice-cold sterile PBS with 1× pro-
tease inhibitors (cOmplete EDTA-Free, Roche, #11873580001) and
10 µM Y-27632 (ROCK I inhibitor, Selleck Chemicals, #S1049) to
inhibit spontaneous apoptosis. The jejunum was moved into a
15-mL conical tube containing 3 mM EDTA in PBS with 1× prote-
ase inhibitors and 10 µMY-27632. The tissuewas placed on a nuta-
tor in a cold room for 15 min. The jejunumwas removed from the
3 mM EDTA and placed on an ice-cold glass Petri dish with PBS
containing 1mMMgCl2 and 2mMCaCl2 with protease inhibitors
and 10 µM Y-27632. Villi were scraped off of the tissue using the
side of a sterile plastic micropipette and transferred into a new
15-mL conical tube. The isolated IECs were then crosslinked for
ChIP-seq, ChIP-PCR or used for DNase-seq or RNA-seq. For addi-
tional information, see Supplemental Methods.
Bioinformatic and statistical analysis
Sample sizes for zebrafish experiments (noted in figure legends)
were selected based on genotype availability and transgenesis effi-
ciency. All sample collection was performed two or more times on
independent days. For sequencing experiments, statistical calls for
differential gene expressionweremade by Cuffdiff2 (Trapnell et al.
2013). For the zebrafish RNA-seq experiment, next-generation se-
quencing was performed once and at the same time to avoid batch
effects: WTGF and WTCV (n = 3); MutGF and MutCV (n = 2). We
originally collected n = 3 MutGF and MutCV biological replicates;
however, using pre-established criteria and to avoid RNA contam-
ination, we excluded one biological replicate from all analysis from
these groups because of sequencing reads that mapped within the
deleted hnf4a exon in the hnf4a−/− genotype.
GFmicewere randomly chosen by gnotobiotic staff formicro-
biota colonization (CV) based on their availability and litter sizes.
All sample collection was performed two or more times per
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condition on independent days. GF and CV mouse samples were
collected on different days. For sequencing experiments, statistical
calls for differential gene expression and differential peak calls
were made by Cuffdiff2, MACS2, and DESeq2 (Zhang et al. 2008;
Anders and Huber 2010; Trapnell et al. 2013; Love et al. 2014).
For the mouse RNA-seq experiment, next-generation sequencing
was performed once and at the same time to avoid batch effects:
GF (n = 2) and CV (n = 2). Paired GF and CV ChIP and library am-
plification was performed simultaneously. Typically, biological
ChIP replicates were sequenced on different days and were always
paired with the other condition (i.e., CV and GF were always se-
quenced together). The number of biological ChIP replicates (not-
ed in figure legends) was dependent on reproducibility between
ChIP samples and/or our ability to determine statistical differential
sites using DESeq2 (for H3K4me1 and H3K27ac).
All statistical metrics (except where otherwise noted) were
performed in Graphpad Prism 7.01. Deming linear regression
was used for Figure 5 because it is a stronger and more accurate as-
sessment of correlation when both the x and y variables have ex-
perimental error. Details regarding the other statistical tests used
in this study can be found in the figure legends or above.
For detailed methods on animal husbandry, zebrafish trans-
genesis, zebrafish mutagenesis, imaging, immunostaining, site-di-
rected mutagenesis, and ChIP-, RNA-, and DNase-seq preparation
and analysis, please see Supplemental Methods.
Data access
Transcription factor ChIP-seq, Histone ChIP-seq, DNase-seq, and
RNA-seq data sets from this study have been submitted to the
NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.
nih.gov/geo/) under accession number GSE90462.
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